Daniel Kalinovsky

451 total citations
10 papers, 331 citations indexed

About

Daniel Kalinovsky is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniel Kalinovsky has authored 10 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniel Kalinovsky's work include Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (5 papers) and Neuroblastoma Research and Treatments (5 papers). Daniel Kalinovsky is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (5 papers) and Neuroblastoma Research and Treatments (5 papers). Daniel Kalinovsky collaborates with scholars based in Russia, United States and Belarus. Daniel Kalinovsky's co-authors include И. В. Холоденко, Р. В. Холоденко, Igor I. Doronin, Sergey M. Deyev, Eugene D. Ponomarev, E. V. Svirshchevskaya, Sergey S. Larin, А. В. Кибардин, Maxim Sorokin and Andrey A. Mironov and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and Current Medicinal Chemistry.

In The Last Decade

Daniel Kalinovsky

8 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Kalinovsky Russia	7	180	150	115	102	60	10	331
Kentaro Otake Japan	8	280 1.6×	56 0.4×	43 0.4×	56 0.5×	87 1.4×	13	364
Karen Kaucic United States	9	177 1.0×	74 0.5×	75 0.7×	25 0.2×	48 0.8×	12	296
Johanna Dzieran Germany	10	235 1.3×	92 0.6×	84 0.7×	21 0.2×	99 1.6×	12	379
Susanne Bryde Netherlands	7	196 1.1×	102 0.7×	65 0.6×	39 0.4×	27 0.5×	7	435
Michaël H. Meel Netherlands	13	172 1.0×	52 0.3×	68 0.6×	31 0.3×	65 1.1×	20	367
Klaartje Somers Belgium	11	144 0.8×	25 0.2×	40 0.3×	112 1.1×	15 0.3×	24	358
Cori Bradley United States	7	160 0.9×	99 0.7×	138 1.2×	12 0.1×	63 1.1×	8	308
Manuel F. Bande Spain	9	110 0.6×	21 0.1×	59 0.5×	67 0.7×	40 0.7×	33	325
Noriyuki Kijima Japan	9	119 0.7×	53 0.4×	88 0.8×	27 0.3×	36 0.6×	40	295
Thomas D. Southgate United Kingdom	11	203 1.1×	22 0.1×	107 0.9×	24 0.2×	39 0.7×	16	361

Countries citing papers authored by Daniel Kalinovsky

Since Specialization

Citations

This map shows the geographic impact of Daniel Kalinovsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Kalinovsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Kalinovsky more than expected).

Fields of papers citing papers by Daniel Kalinovsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Kalinovsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Kalinovsky. The network helps show where Daniel Kalinovsky may publish in the future.

Co-authorship network of co-authors of Daniel Kalinovsky

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Kalinovsky. A scholar is included among the top collaborators of Daniel Kalinovsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Kalinovsky. Daniel Kalinovsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Kalinovsky, Daniel, И. В. Холоденко, А. В. Кибардин, et al.. (2025). Endocytosis Properties of GD2-Specific Antibodies in Tumor Cells. Biochemistry (Moscow). 90(3). 424–435.

Ryazantsev, D. Yu., et al.. (2024). Expression of extracellular fragment of murine PD-L1 and production of antibodies to PD-L1. Биоорганическая химия. 50(6). 871–882.

Kalinovsky, Daniel, И. В. Холоденко, А. В. Кибардин, et al.. (2023). Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells. International Journal of Molecular Sciences. 24(2). 1239–1239. 20 indexed citations

Kalinovsky, Daniel, И. В. Холоденко, E. V. Svirshchevskaya, et al.. (2023). Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment–Drug Conjugates Carrying Maytansinoids DM1 and DM4. Current Issues in Molecular Biology. 45(10). 8112–8125. 6 indexed citations

Kalinovsky, Daniel, А. В. Кибардин, И. В. Холоденко, et al.. (2022). Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors. Journal for ImmunoTherapy of Cancer. 10(6). e004646–e004646. 20 indexed citations

Sorokin, Maxim, И. В. Холоденко, Daniel Kalinovsky, et al.. (2020). RNA Sequencing-Based Identification of Ganglioside GD2-Positive Cancer Phenotype. Biomedicines. 8(6). 142–142. 30 indexed citations

Pestov, Nikolay B., et al.. (2019). Properties of a cryptic lysyl oxidase from haloarchaeon Haloterrigena turkmenica. PeerJ. 7. e6691–e6691. 1 indexed citations

Холоденко, И. В., Daniel Kalinovsky, E. V. Svirshchevskaya, et al.. (2019). Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies. Molecules. 24(21). 3835–3835. 28 indexed citations

Холоденко, Р. В., Daniel Kalinovsky, Igor I. Doronin, Eugene D. Ponomarev, & И. В. Холоденко. (2019). Antibody Fragments as Potential Biopharmaceuticals for Cancer Therapy: Success and Limitations. Current Medicinal Chemistry. 26(3). 396–426. 83 indexed citations

10.

Холоденко, И. В., Daniel Kalinovsky, Igor I. Doronin, Sergey M. Deyev, & Р. В. Холоденко. (2018). Neuroblastoma Origin and Therapeutic Targets for Immunotherapy. Journal of Immunology Research. 2018. 1–25. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact